Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PhenixFIN (PFX) Cash & Equivalents (2021 - 2025)

PhenixFIN (PFX) has disclosed Cash & Equivalents for 5 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 52.6% to $3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 million, a 52.6% decrease, with the full-year FY2025 number at $7.3 million, down 89.21% from a year prior.
  • Cash & Equivalents was $3.4 million for Q4 2025 at PhenixFIN, down from $7.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $67.6 million in Q3 2024 to a low of $3.4 million in Q4 2025.
  • A 5-year average of $19.5 million and a median of $10.9 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 1028.41% in 2024, then plummeted 89.21% in 2025.
  • PhenixFIN's Cash & Equivalents stood at $59.4 million in 2021, then tumbled by 70.27% to $17.7 million in 2022, then tumbled by 31.04% to $12.2 million in 2023, then crashed by 40.96% to $7.2 million in 2024, then crashed by 52.6% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for PFX's Cash & Equivalents are $3.4 million (Q4 2025), $7.3 million (Q3 2025), and $7.3 million (Q2 2025).